Literature DB >> 20426711

Therapy of pruritus.

Tejesh Patel1, Gil Yosipovitch.   

Abstract

IMPORTANCE OF THE FIELD: Pruritus is the predominant symptom of skin disease. Owing to the poorly understood pathophysiology, the development of effective treatment modalities for pruritus has proven to be particularly difficult. At present, there is no universally accepted therapy for itch. The purpose of this review is to provide an update on the treatment of pruritus. AREAS COVERED IN THIS REVIEW: An overview of current, emerging and possible future therapies for pruritus is provided. WHAT THE READER WILL GAIN: Insights into possible treatment regimes for pruritus in different clinical scenarios. TAKE HOME MESSAGE: The therapy of pruritus is challenging and at present takes on an individualistic approach. Recent advancements in the mechanisms that underlie this distressing symptom have identified new targets for future therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426711      PMCID: PMC2885583          DOI: 10.1517/14656566.2010.484420

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  93 in total

1.  Treatment of prurigo nodularis with topical capsaicin.

Authors:  S Ständer; T Luger; D Metze
Journal:  J Am Acad Dermatol       Date:  2001-03       Impact factor: 11.527

2.  Identification of a cold receptor reveals a general role for TRP channels in thermosensation.

Authors:  David D McKemy; Werner M Neuhausser; David Julius
Journal:  Nature       Date:  2002-02-10       Impact factor: 49.962

Review 3.  The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission.

Authors:  T de Boer
Journal:  Int Clin Psychopharmacol       Date:  1995-12       Impact factor: 1.659

4.  Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.

Authors:  N V Bergasa; D W Alling; T L Talbot; M C Wells; E A Jones
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

Review 5.  New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma.

Authors:  Hui Wang; Gil Yosipovitch
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

6.  Treatment of pruritus with topically applied opiate receptor antagonist.

Authors:  Paul L Bigliardi; Holger Stammer; Gerhard Jost; Theo Rufli; Stanislaw Büchner; Mei Bigliardi-Qi
Journal:  J Am Acad Dermatol       Date:  2007-02-22       Impact factor: 11.527

7.  Randomised crossover trial of naltrexone in uraemic pruritus.

Authors:  G Peer; S Kivity; O Agami; E Fireman; D Silverberg; M Blum; A laina
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

8.  Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.

Authors:  F Malekzad; M Arbabi; N Mohtasham; P Toosi; M Jaberian; M Mohajer; M R Mohammadi; M R Roodsari; S Nasiri
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-05-06       Impact factor: 6.166

Review 9.  Nocturnal itch: why do we itch at night?

Authors:  Tejesh Patel; Yozo Ishiuji; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

10.  Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.

Authors:  Sonja Ständer; Barbara Böckenholt; Funda Schürmeyer-Horst; Carsten Weishaupt; Gereon Heuft; Thomas A Luger; Gudrun Schneider
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

View more
  29 in total

1.  The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats.

Authors:  Pin-Yen Su; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2011-03-18       Impact factor: 4.030

2.  Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice.

Authors:  Peng-Bo Jing; De-Li Cao; Si-Si Li; Meixuan Zhu; Xue-Qiang Bai; Xiao-Bo Wu; Yong-Jing Gao
Journal:  Neurosci Bull       Date:  2017-04-11       Impact factor: 5.203

3.  Pruritus in the elderly: clinical approaches to the improvement of quality of life.

Authors:  Kenneth R Cohen; Jerry Frank; Rebecca L Salbu; Igor Israel
Journal:  P T       Date:  2012-04

Review 4.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

5.  Enhanced nonpeptidergic intraepidermal fiber density and an expanded subset of chloroquine-responsive trigeminal neurons in a mouse model of dry skin itch.

Authors:  Manouela V Valtcheva; Vijay K Samineni; Judith P Golden; Robert W Gereau; Steve Davidson
Journal:  J Pain       Date:  2015-01-30       Impact factor: 5.820

Review 6.  Topical therapies for pruritus.

Authors:  Sarina B Elmariah; Ethan A Lerner
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 7.  Pruritus: management algorithms and experimental therapies.

Authors:  Martin Steinhoff; Ferda Cevikbas; Akihiko Ikoma; Timothy G Berger
Journal:  Semin Cutan Med Surg       Date:  2011-06

8.  Responses of neurons in the primary somatosensory cortex to itch- and pain-producing stimuli in rats.

Authors:  Sergey G Khasabov; Hai Truong; Victoria M Rogness; Kevin D Alloway; Donald A Simone; Glenn J Giesler
Journal:  J Neurophysiol       Date:  2020-04-15       Impact factor: 2.714

Review 9.  Trp channels and itch.

Authors:  Shuohao Sun; Xinzhong Dong
Journal:  Semin Immunopathol       Date:  2015-09-18       Impact factor: 9.623

Review 10.  Anogenital Pruritus - An Overview.

Authors:  Murugan Swamiappan
Journal:  J Clin Diagn Res       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.